FASEB SRC on Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation and Can

描述(由申请人提供)：本申请请求支持FASEB夏季会议，题为“胃肠道XV：上皮、微生物、炎症和癌症”(联席主席阿斯玛·努斯拉特博士、罗伯特·科菲博士和塞迪乌斯·斯塔彭贝克博士)。为期5天的会议将是一系列两年一次的会议中的第15次，在过去的28年里，这些会议为处于胃肠道健康和疾病相关领域研究前沿的科学家提供了一个激烈和亲密的展示、讨论和思想交流的场所。在发育、上皮/干细胞生物学、粘膜免疫学、微生物学和胃肠道生理学方面的快速科学进步决定了继续这一系列会议的必要性，与会者在2011年8月14-18日在科罗拉多州斯普林斯举行的最后一次会议上一致投票同意了这一系列会议。我们预计将有约160名科学家和实习生参加2013年会议，该会议将于2013年8月11日至15日在科罗拉多州斯普林斯举行。许多主题与NIDDK任务的目标高度相关，包括胃肠道癌症干细胞、宿主与病原体的相互作用、微生物生态学、粘膜免疫、炎症和上皮特性/修复。我们已经开发了一种格式，旨在促进将基础生物学转换为与人类疾病相关的新医学方法。汽船会议中心是一个久负盛名的FASEB会议场所，设备齐全，非常适合支持这次会议。已经确认了本次会议的41名发言者和会议主席。此外，还计划了两个海报会议，13个摘要将被选为口头陈述，一个下午将专门用于专家会议和NIH研讨会。

DESCRIPTION (provided by applicant): This application requests support for a FASEB Summer Conference entitled "Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation and Cancer" (Drs. Asma Nusrat, Robert Coffey, and Thaddeus Stappenbeck, co-chairs). The 5 day conference will be the 15th in a series of biennial meetings that over the last 28 years has provided an intense and intimate venue for presentation, discussion, and exchange of ideas among scientists at the forefront of research in fields related to gastrointestinal health and disease. The rapid scientific advances in development, epithelial/stem cell biology, mucosal immunology, microbiology and physiology of the gastrointestinal (GI) tract dictate the need to continue this series of conferences, which was agreed upon by the unanimous vote of attendees at the last meeting, held August 14-18, 2011, at Steamboat Springs, Colorado. We anticipate the attendance of ~ 160 scientists and trainees at the 2013 meeting that will be held at Steamboat Springs, Colorado from August 11-15, 2013. Many of the topics are highly relevant to the goals of the NIDDK mission including gastrointestinal cancer stem cells, host-pathogen interactions, microbial ecology, mucosal immunity, inflammation and epithelial properties/repair. We have developed a format that is designed to facilitate translation of basic biology into new medically relevant approaches to human disease. The Steamboat Conference Center is a well-established site for FASEB conferences and is fully equipped and well suited to support this meeting. Forty-one speakers and session chairs have been confirmed for this meeting. In addition, two poster sessions are planned, thirteen abstracts will be selected for oral presentation and an afternoon will be devoted to a Meet the Experts and an NIH workshops.